Given the vasoactive response induced by ET-1, its potential role in cardiovascular diseases and the effects of elevation in ET-1 circulating plasma levels have been studied and described in many vascular diseases, such as atherosclerosis, systemic hypertension, and pulmonary hypertension [10,11,12]. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.